个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Umbilical Cord Mesenchymal Stem Cells Ameliorate Kidney Injury in MRL/Ipr Mice Through the TGF-β1 Pathway.

| 导出 | |

文献详情

资源类型：
WOS体系：
Pubmed体系：

收录情况： ◇ SCIE ◇ 预警期刊

作者：
Huang Chunkai[1,2,3] ; Meng Mingyao[1,2,3] ; Li Shuo[1,2,3] ; Liu Shiyuan[1,2,3] ; Li Lin[1,2,3] ; Su Yanjun[4] ; Gao Hui[1,2,3] ; He Shan[1,2,3] ; Zhao Yiyi[1,2,3] ; Zhang Min[4] ; Hou Zongliu[1,2,3] ; Wang Wenju[1,2,3] ; Wang Xiaodan[1,2,3] ;
机构： [1]Scientific Research Department, Yan’an Hospital Affiliated to Kunming Medical University, Kunming, China, [2]Key Laboratory of Tumor Immunological Prevention and Treatment of Yunnan Province, Kunming, China, [3]Yunnan Cell Biology and Clinical Translation Research Center, Kunming, China, [4]Thyroid Surgery, The First Affiliated Hospital of Kunming Medical University, Kunming, China
出处：
DOI： 10.3389/fcell.2022.876054
ISSN：

关键词： lupus nephritis umbilical cord mesenchymal stem cells podocytes TGF-β1 p-Smad3 TRAF6

摘要：
The therapeutic effects and mechanism of umbilical cord mesenchymal stem cells (UC-MSC) on kidney injury in MRL/Ipr mice were studied. UC-MSC, methylprednisolone (MP), and their combination were used to treat MRL/Ipr mice. The therapeutic effects were evaluated by renal function assessment, and HE, PAS, and Masson staining were carried out on renal tissues and visualized by electron microscopy. Subsequently, podocyte injury was detected by the presence of podocin in renal tissues by immunofluorescence. To further explore the mechanism, serum TGF-β1 was measured, and TGF-β1, p-Smad3, and TRAF6 in the renal tissue were detected by Western blotting. In vitro, TGF-β1 was used to stimulate podocytes, and the podocyte activity and changes in synaptopodin were observed after UC-MSC treatment. Significant improvements in renal function and pathological injury were observed in the UC-MSC group compared to the lupus nephritis (LN) model group. UC-MSC and MP treatment improved podocyte injury in MRL/Ipr mice. Western blot examination showed a significant increase in TGF-β1, p-Smad3, and TRAF6 expression in renal tissues of the LN model group, while significant downregulation of those proteins was observed in the UC-MSC group. After TGF-β1 stimulation in vitro, podocyte activity decreased, and UC-MSC treatment improved podocyte activity and restored synaptopodin expression. UC-MSC therapy could improve the deterioration of renal function and the pathological changes of the renal tissues in MRL/Ipr mice. Our study suggested that UC-MSC may improve kidney injury and podocyte injury in LN mice by inhibiting the TGF-β1 pathway.Copyright © 2022 Huang, Meng, Li, Liu, Li, Su, Gao, He, Zhao, Zhang, Hou, Wang and Wang.

基金：
National Natural Science Foundation of China (No. 81960136) and the Science and Technology Department of Yunnan Province (Nos. 202003AC100014 and 202101AT070243).
语种：
外文
被引次数：
WOS：
PubmedID：
中科院(CAS)分区：
出版当年[2023]版：
大类 | 2 区 生物学
小类 | 2 区 发育生物学 3 区 细胞生物学
最新[2023]版：
大类 | 2 区 生物学
小类 | 2 区 发育生物学 3 区 细胞生物学
JCR分区：
出版当年[2022]版：
Q1 DEVELOPMENTAL BIOLOGY Q2 CELL BIOLOGY
最新[2023]版：
Q1 DEVELOPMENTAL BIOLOGY Q2 CELL BIOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者：
第一作者机构： [1]Scientific Research Department, Yan’an Hospital Affiliated to Kunming Medical University, Kunming, China, [2]Key Laboratory of Tumor Immunological Prevention and Treatment of Yunnan Province, Kunming, China, [3]Yunnan Cell Biology and Clinical Translation Research Center, Kunming, China,
共同第一作者：
通讯作者：
通讯机构： [1]Scientific Research Department, Yan’an Hospital Affiliated to Kunming Medical University, Kunming, China, [2]Key Laboratory of Tumor Immunological Prevention and Treatment of Yunnan Province, Kunming, China, [3]Yunnan Cell Biology and Clinical Translation Research Center, Kunming, China,
推荐引用方式(GB/T 7714)：
Huang Chunkai,Meng Mingyao,Li Shuo,et al.Umbilical Cord Mesenchymal Stem Cells Ameliorate Kidney Injury in MRL/Ipr Mice Through the TGF-β1 Pathway.[J].FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY.2022,10:doi:10.3389/fcell.2022.876054.
APA：
Huang Chunkai,Meng Mingyao,Li Shuo,Liu Shiyuan,Li Lin...&Wang Xiaodan.(2022).Umbilical Cord Mesenchymal Stem Cells Ameliorate Kidney Injury in MRL/Ipr Mice Through the TGF-β1 Pathway..FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY,10,
MLA：
Huang Chunkai,et al."Umbilical Cord Mesenchymal Stem Cells Ameliorate Kidney Injury in MRL/Ipr Mice Through the TGF-β1 Pathway.".FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 10.(2022)

相关文献

[1]Influence of Wnt/beta-catenin signal transduction pathway on the differentiation of umbilical cord mesenchymal stem cells into hepatocyte-like cells [2]Condition medium of HepG-2 cells induces the transdifferentiation of human umbilical cord mesenchymal stem cells into cancerous mesenchymal stem cells. [3]Differentiation of human umbilical cord-derived mesenchymal stem cells into hepatocytes in vitro [4]Condition medium of HepG-2 cells induces the transdifferentiation of human umbilical cord mesenchymal stem cells into cancerous mesenchymal stem cells [5]Condition medium of HepG-2 cells induces the transdifferentiation of human umbilical cord mesenchymal stem cells into cancerous mesenchymal stem cells [6]Integrin subunits alpha V and beta 3 promote the osteogenic differentiation of umbilical cord blood mesenchymal stem cells [7]Clinical remission of a critically ill COVID-19 patient treated by human umbilical cord mesenchymal stem cells: A case report(Open Access) [8]人脐带间充质干细胞的培养鉴定及其向神经元细胞分化的研究 [9]人脐带间充质干细胞在帕金森病的应用进展 [10]脐带间充质干细胞移植治疗难治性系统性红斑狼疮3年随访

资源点击量：52537 今日访问量：0 总访问量：1562 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持：重庆聚合科技有限公司 地址：云南省昆明市西昌路295号(650032)